4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000012
President, Research & Develop. gave up 6,138 shares (to pay taxes)
- President, Research & Develop. acquired 60,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan President, Research & Develop. | 2025-03-01 | Grant or award | +60,800 | 205,797 | D: show line 1 in the form | ||
| Sethuraman Natarajan President, Research & Develop. | 2025-03-03 | Shares withheld for taxes | −6,138 | $11.68 | $71,683 | 199,659 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan President, Research & Develop. | 2025-03-01 | Grant or award · Stock Option (Right to Buy) | +90,800 | 90,800 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1741125479.xml…